FGF21 Revolutions: Recent Advances Illuminating FGF21 Biology and Medicinal Properties

被引:92
作者
Kharitonenkov, Alexei [1 ]
DiMarchi, Richard [1 ]
机构
[1] Indiana Univ, Dept Chem, Bloomington, IN 47405 USA
关键词
GROWTH-FACTOR; 21; INCREASES ENERGY-EXPENDITURE; IMPROVES INSULIN SENSITIVITY; BETA-KLOTHO; PPAR-ALPHA; LEPTIN RESPONSIVENESS; GLUCOSE-HOMEOSTASIS; HEPATIC STEATOSIS; SKELETAL-MUSCLE; METABOLIC-RATE;
D O I
10.1016/j.tem.2015.09.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The biology of fibroblast growth factor 21 (FGF21) has evolved through its first decade at a revolutionary pace with dramatic refinements in this relatively short span of time. This field is poised now with a deeper understanding of its specific physiological role, pathological ramifications for its inappropriate function, and a much-enriched context of the complex hormonal network in which it serves to regulate metabolism. As a derivative of these discoveries, the application of FGF21 as a medicinal agent has emerged with structurally optimized protein-based analogs being preclinically explored in multiple species, and, more recently, through clinical studies. These novel findings set a foundation for ongoing inquiries that structure future research into this intriguing protein.
引用
收藏
页码:608 / 617
页数:10
相关论文
共 97 条
[1]   FGF21: The Center of a Transcriptional Nexus in Metabolic Regulation [J].
Adams, A. C. ;
Kharitonenkov, A. .
CURRENT DIABETES REVIEWS, 2012, 8 (04) :285-293
[2]   The breadth of FGF21's metabolic actions are governed by FGFR1 in adipose tissue [J].
Adams, Andrew C. ;
Yang, Chaofeng ;
Coskun, Tamer ;
Cheng, Christine C. ;
Gimeno, Ruth E. ;
Luo, Yongde ;
Kharitonenkov, Alexei .
MOLECULAR METABOLISM, 2013, 2 (01) :31-37
[3]   LY2405319, an Engineered FGF21 Variant, Improves the Metabolic Status of Diabetic Monkeys [J].
Adams, Andrew C. ;
Halstead, Carolyn A. ;
Hansen, Barbara C. ;
Irizarry, Armando R. ;
Martin, Jennifer A. ;
Myers, Sharon R. ;
Reynolds, Vincent L. ;
Smith, Holly W. ;
Wroblewski, Victor J. ;
Kharitonenkov, Alexei .
PLOS ONE, 2013, 8 (06)
[4]   FGF21 Requires βklotho to Act In Vivo [J].
Adams, Andrew C. ;
Cheng, Christine C. ;
Coskun, Tamer ;
Kharitonenkov, Alexei .
PLOS ONE, 2012, 7 (11)
[5]   Fundamentals of FGF19 & FGF21 Action In Vitro and In Vivo [J].
Adams, Andrew C. ;
Coskun, Tamer ;
Rovira, Armando R. Irizarry ;
Schneider, Michael A. ;
Raches, David W. ;
Micanovic, Radmila ;
Bina, Holly A. ;
Dunbar, James D. ;
Kharitonenkov, Alexei .
PLOS ONE, 2012, 7 (05)
[6]   Circulating Fibroblast Growth Factors as Metabolic Regulators-A Critical Appraisal [J].
Angelin, Bo ;
Larsson, Tobias E. ;
Rudling, Mats .
CELL METABOLISM, 2012, 16 (06) :693-705
[7]  
Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002
[8]   Fibroblast Growth Factor 21 Controls Glycemia via Regulation of Hepatic Glucose Flux and Insulin Sensitivity [J].
Berglund, Eric D. ;
Li, Candice Y. ;
Bina, Holly A. ;
Lynes, Sara E. ;
Michael, M. Dodson ;
Shanafelt, Armen B. ;
Kharitonenkov, Alexei ;
Wasserman, David H. .
ENDOCRINOLOGY, 2009, 150 (09) :4084-4093
[9]   FGF21 regulates metabolism and circadian behavior by acting on the nervous system [J].
Bookout, Angie L. ;
de Groot, Marleen H. M. ;
Owen, Bryn M. ;
Lee, Syann ;
Gautron, Laurent ;
Lawrence, Heather L. ;
Ding, Xunshan ;
Elmquist, Joel K. ;
Takahashi, Joseph S. ;
Mangelsdorf, David J. ;
Kliewer, Steven A. .
NATURE MEDICINE, 2013, 19 (09) :1147-1152
[10]   Pegylated Fgf21 rapidly normalizes insulin-stimulated glucose utilization in diet-induced insulin resistant mice [J].
Camacho, Raul C. ;
Zafian, Peter T. ;
Achanfuo-Yeboah, Joana ;
Manibusan, Anthony ;
Berger, Joel P. .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2013, 715 (1-3) :41-45